Predictive value of past and current screening tests for syphilis in blood donors: changing from a rapid plasma reagin test to an automated specific treponemal test for screening.
BACKGROUND
This study evaluated the change from a rapid plasma reagin (RPR) test to an automated specific treponemal test (PK-TP) in screening for syphilis in blood donors.


METHODS
A cross-sectional seroprevalence analysis was performed on 4,878,215 allogeneic blood donations from 19 American Red Cross Blood Services regions from May 1993 through September 1995. Positive predictive values relative to the confirmatory fluorescent treponemal antibody absorption test (FTA-ABS) were calculated. Differences in seroprevalence were compared in RPR and PK-TP tests for 1) unconfirmed and confirmed tests, 2) first-time and repeat donors, and 3) "recent" versus "past" infections. Donation data from three additional Red Cross regions were evaluated for repeat donation patterns of blood donors who had a donation that was positive in a serologic screening test for syphilis. The value of RPR and PK-TP tests as surrogate markers for HIV infection was compared.


RESULTS
Reactive rates were lower but the positive predictive values was higher for the PK-TP test than for the RPR test. Initially, donors screened by PK-TP were more likely to be confirmed as positive than were donors screened by RPR, but these rates became comparable. It is estimated that a single HIV window-period donation was removed by serologic testing for syphilis each year of this study period.


CONCLUSIONS
The change to the PK-TP test resulted in a lower repeatedly reactive rate, better prediction that a confirmed-positive test for syphilis would occur in testing in the FTA-ABS, fewer donations lost, and comparable deferral rates. Because of the high rate of reactivity to serologic testing for syphilis among donors previously confirmed positive for syphilis, indefinite deferral after a confirmed-positive index donation may be warranted. Serologic testing for syphilis is ineffective as a marker of HIV-infectious window-period donations.
Holland Laboratory, American Red Cross Blood Services, Rockville, Maryland 20855, USA.
J
J
Aberle-Grasse
S L
SL
Orton
E
E
Notari
L P
LP
Layug
R G
RG
Cable
S
S
Badon
M A
MA
Popovsky
A J
AJ
Grindon
B A
BA
Lenes
A E
AE
Williams
D000918:Antibody Specificity; D001322:Autoanalysis; D001782:Blood Donors; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D010949:Plasma / Q000276:immunology; D011237:Predictive Value of Tests; D015995:Prevalence; D011935:Reagins / Q000097:blood*; D013587:Syphilis / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology; D014208:Treponema / Q000276:immunology*; D014481:United States / Q000453:epidemiology
D011935:Reagins